
Cedil 250mg/31.25mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Cedil 250mg/31.25mg Injection
Combiflox 250 mg/31.25 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication only as directed by a healthcare provider; adhere strictly to the prescribed schedule, completing the entire course even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions, such as redness, swelling, and pain, may occur but typically resolve spontaneously. Severe or persistent side effects necessitate immediate medical attention. Seek emergency care for allergic reactions manifested as rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing drowsiness or dizziness.
Uses of Cedil 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cedil 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cedil 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Cedil 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cedil 250mg/31.25mg Injection works:
Cefepime/Tazobactum 250 mg/31.25 mg Injection combines the antibiotic Cefepime with the beta-lactamase inhibitor Tazobactum. Cefepime disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cedil 250 mg/31.25 mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Administration of Cedil 250 mg/31.25 mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Cedil 250 mg/31.25 mg Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Following administration of Cedil 250 mg/31.25 mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
For individuals with impaired kidney function, administration of Cedil 250 mg/31.25 mg Injection requires careful consideration. Dosage modification of Cedil 250 mg/31.25 mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Cedil 250 mg/31.25 mg Injection in patients with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Cedil 250mg/31.25mg Injection :
Should you forget a scheduled dose of Cedil 250 mg/31.25 mg Injection, seek medical advice.
Facts to Know About Cedil 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
